We are live on ! Find out more
Versant Venture Management

Versant Venture Management Portfolio holdings

AUM $163M Turnover 0%
1-Year Est. Return 240.43%
This Fund
S&P 500
This Quarter Est. Return
+30.38%
1 Year Est. Return
+240.43%
3 Year Est. Return
+409.28%
5 Year Est. Return
+142.09%
10 Year Est. Return
+4,071.98%
AUM
$163M
AUM Growth
+$21.2M
Cap. Flow
-$11.1M
Cap. Flow %
-6.85%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
–
Avg Time Held
2.2 years
Top 10 Avg Time Held
2.2 years
Top 20 Avg Time Held
2.2 years

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
JBIO icon
Jade Biosciences
JBIO
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GLUE icon
1
Monte Rosa Therapeutics
GLUE
$923M
$77M 47.34%
3,180,780
– –
2024 Q4
6 quarters
IPSC icon
2
Century Therapeutics
IPSC
$302M
$29.8M 18.33%
12,166,109
– –
2026 Q1
1 quarter
JBIO icon
3
Jade Biosciences
JBIO
$957M
$22M 13.55%
991,783
-534,037
-35% -$11.1M
2025 Q2
4 quarters
LENZ icon
4
LENZ Therapeutics
LENZ
$109M
$15.1M 9.28%
2,656,888
– –
2025 Q3
3 quarters
CTNM icon
5
Contineum Therapeutics
CTNM
$368M
$8.89M 5.47%
542,628
– –
2024 Q2
8 quarters
CRSP icon
6
CRISPR Therapeutics
CRSP
$5.01B
$8.12M 4.99%
148,831
– –
2018 Q1
33 quarters
SKYE icon
7
Skye Bioscience
SKYE
$5.05M
$1.39M 0.86%
250,963
– –
2024 Q2
8 quarters
TPST icon
8
Tempest Therapeutics
TPST
$9.26M
$299K 0.18%
269,772
– –
2024 Q4
6 quarters

Similar funds

Arrington Capital Management
Arrington Capital Management Miami, Florida $163M AUM
Value Base
Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return
Candelo Capital Management
Candelo Capital Management New York $162M AUM 112.87% 1-Year Est. Return
Generation Capital Management
Generation Capital Management Pittsford, New York $163M AUM 42.22% 1-Year Est. Return
Cornerstone Financial Group
Cornerstone Financial Group Omaha, Nebraska $162M AUM 14.64% 1-Year Est. Return
MCS
Mercuria Capital Strategies Houston, Texas $163M AUM 258.7% 1-Year Est. Return
Cruiser Capital Advisors
Cruiser Capital Advisors Stamford, Connecticut $162M AUM 78.28% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM

Versant Venture Management's Q2 2026 Portfolio in Review

As of Q2 2026, Versant Venture Management held 8 positions worth $163M, up 15% from $141M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Versant Venture Management withdrew a net $11.1M in Q2 2026, reducing 1 holding. Its largest reduction was Jade Biosciences, cutting an estimated $11.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Versant Venture Management's biggest Q2 2026 reduction was Jade Biosciences, cutting an estimated $11.1M.
  • Versant Venture Management's ten largest holdings make up 100% of its $163M portfolio in Q2 2026.
  • Versant Venture Management opened 0 new positions and closed 0 in Q2 2026.
  • Versant Venture Management's portfolio value rose 15% quarter-over-quarter to $163M.

Based on Versant Venture Management's 13F filing for Q2 2026, filed 12 Aug 2026.